- Home
- MESA vs SER Comparison
MESA vs SER Comparison
Compare MESA & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- SER
- Stock Information
- Founded
- MESA 1982
- SER 2017
- Country
- MESA United States
- SER United States
- Employees
- MESA N/A
- SER N/A
- Industry
- MESA Air Freight/Delivery Services
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- SER Health Care
- Exchange
- MESA Nasdaq
- SER Nasdaq
- Market Cap
- MESA 46.7M
- SER 45.2M
- IPO Year
- MESA 2018
- SER 2018
- Fundamental
- Price
- MESA $1.33
- SER $4.81
- Analyst Decision
- MESA
- SER
- Analyst Count
- MESA 0
- SER 0
- Target Price
- MESA N/A
- SER N/A
- AVG Volume (30 Days)
- MESA 309.7K
- SER 31.9K
- Earning Date
- MESA 01-28-2025
- SER 11-12-2024
- Dividend Yield
- MESA N/A
- SER N/A
- EPS Growth
- MESA N/A
- SER N/A
- EPS
- MESA N/A
- SER N/A
- Revenue
- MESA $475,518,000.00
- SER $3,157,500.00
- Revenue This Year
- MESA $15.09
- SER N/A
- Revenue Next Year
- MESA $16.19
- SER N/A
- P/E Ratio
- MESA N/A
- SER N/A
- Revenue Growth
- MESA N/A
- SER 2454.55
- 52 Week Low
- MESA $0.75
- SER $3.81
- 52 Week High
- MESA $1.89
- SER $19.93
- Technical
- Relative Strength Index (RSI)
- MESA 61.58
- SER 46.26
- Support Level
- MESA $1.29
- SER $4.70
- Resistance Level
- MESA $1.41
- SER $5.40
- Average True Range (ATR)
- MESA 0.10
- SER 0.49
- MACD
- MESA -0.00
- SER -0.01
- Stochastic Oscillator
- MESA 62.96
- SER 11.93
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.